Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
29.45
-0.29 (-0.98%)
At close: Aug 19, 2025, 3:59 PM
30.24
2.68%
After-hours: Aug 19, 2025, 07:42 PM EDT
Crinetics Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -115.64M | -96.77M | -80.59M | -76.83M | -74.06M | -66.93M | -60.1M | -57.46M | -50.98M | -45.99M | -44.99M | -41.92M | -42.38M | -34.63M | -30.79M | -27.85M | -26.09M | -22.9M |
Depreciation & Amortization | 959K | 925K | 788K | 770K | 753K | 474K | 262K | 273K | 280K | 283K | 280K | 248K | 215K | 240K | 235K | 233K | 230K | 224K |
Stock-Based Compensation | 26.12M | 20.48M | 18.84M | 18.15M | 18.94M | 13.45M | 11.62M | 11.05M | 10.18M | 8.1M | 7.95M | 7.43M | 7.13M | 5.75M | 5.16M | 4.55M | 4.23M | 3.41M |
Other Working Capital | 9.54M | -8.18M | -8.62M | -5.55M | 4.17M | 1.39M | 4.11M | 470K | -11.84M | 658K | -385K | -2.88M | -1.45M | 12.13M | -586K | -3.27M | -658K | -688K |
Other Non-Cash Items | -6.83M | -3.54M | -3.4M | 9.18M | -2.66M | -2.55M | 1.4M | 7.15M | 118K | -2.42M | -812K | -29K | 264K | 1.43M | -996K | 95K | 82K | 80K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.21M | -905K | n/a | n/a | n/a | n/a | n/a | 186K | 66K | 87K | 83K |
Change in Working Capital | 9.54M | -9.54M | -308K | -14.1M | 11.4M | 2.69M | 8.3M | 4.85M | -4.42M | -687K | 2.37M | -4.21M | 6.79M | 13.66M | 3.31M | -2.77M | 1.51M | -959K |
Operating Cash Flow | -85.85M | -88.45M | -64.67M | -62.82M | -45.62M | -52.86M | -38.52M | -41.34M | -45.73M | -40.72M | -35.21M | -38.48M | -27.98M | -13.54M | -22.9M | -25.67M | -19.95M | -20.07M |
Capital Expenditures | -3.2M | -1.24M | -1.03M | -528K | -955K | -1.33M | -935K | -3.5M | -237K | -16K | -274K | -682K | -613K | -87K | -18K | -140K | -162K | -116K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 189.8M | -31.67M | -530K | 34K | -7.5M | 173.66M | 322K | 101.8M | n/a | n/a | 83K |
Purchase of Investments | -191.97M | -391.2M | -725.03M | -140.78M | -191.99M | -99.74M | -173.05M | -277.64M | -59.49M | -22.67M | -33.56M | -48.68M | -192.56M | -55.02M | -102.02M | -20.84M | n/a | -2.54M |
Sales Maturities Of Investments | 224.03M | 306.48M | 183.97M | 151.15M | 139.3M | 101.38M | 86.68M | 87.84M | 91.17M | 71.44M | 70.69M | 56.19M | 18.9M | 11.72M | 244K | 13.96M | 20M | 35.15M |
Other Investing Acitivies | 9.09M | n/a | n/a | 10.77M | n/a | n/a | n/a | -189.8M | 31.67M | 530K | -34K | 7.5M | -173.66M | -322K | -101.8M | -6.88M | 20M | -83K |
Investing Cash Flow | 37.95M | -85.96M | -542.09M | 20.6M | -53.64M | 309K | -87.31M | -193.3M | 31.44M | 48.76M | 36.85M | 6.82M | -174.27M | -43.38M | -101.8M | -7.03M | 19.84M | 32.5M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 10.68M | n/a | 10.36M | 9.17M | 8.92M | 1.35M | 484K | 115K | 1.08M | 118.99M | 1.78M | 1.85M | 487K | 745K | 57K |
Financial Cash Flow | 7.05M | 4.44M | 554.04M | 57.33M | 5.5M | 393.57M | 37.92M | 337.88M | 12.66M | 484K | 115K | 1.08M | 118.99M | 1.78M | 163.86M | 15.46M | 73.3M | 57K |
Net Cash Flow | -40.84M | -169.98M | -52.72M | 15.11M | -93.76M | 341.03M | -87.9M | 103.24M | -1.64M | 8.52M | 1.76M | -30.58M | -83.25M | -55.15M | 39.16M | -17.23M | 73.19M | 12.49M |
Free Cash Flow | -89.05M | -89.69M | -65.7M | -63.35M | -46.57M | -54.19M | -39.45M | -44.84M | -45.97M | -40.73M | -35.48M | -39.16M | -28.59M | -13.63M | -22.92M | -25.81M | -20.11M | -20.18M |